Somerset County Maryland

Resilience Network

Main menu


You are here

Home

Moderna's clinical trial numbers show there's 'no way' Trump can have a vaccine by Election Day

Primary tabs

Mon, 2020-08-10 19:33 — mike kraft
Moderna's clinical trial numbers show there's 'no way' Trump can have a vaccine by Election Day Contrary to his predictions, President Trump won't have a coronavirus vaccine ready by Election Day, vaccine experts tell CNN after reviewing data from Moderna, the first company to begin its Phase 3 clinical trials of a coronavirus vaccine in the United States. Elizabeth Cohen, CNN Senior Medical Correspondent CNN

(CNN)Contrary to his predictions, President Trump won't have a coronavirus vaccine ready by Election Day, vaccine experts tell CNN after reviewing data from Moderna, the first company to begin its Phase 3 clinical trials of a coronavirus vaccine in the United States.

There's no way. There's just no way," said Dr. Peter Hotez, a vaccinologist at Baylor College of Medicine and a CNN medical analyst.
Last week President Trump said he was "optimistic" a vaccine would be ready around Election Day on November 3.
 
 
    "I believe we'll have the vaccine before the end of the year, certainly, but around that date, yes. I think so," Trump said Thursday.
    CNN obtained part of an email Moderna sent on Friday to the principal investigators of its vaccine trials. It says 4,536 study subjects have enrolled in the trials.
     
    The trial started the morning of July 27 and intends to enroll 30,000 study subjects. The company has said it's "on track to complete enrollment in September."
     
    Moderna won't make that 30,000 in September if they continue at the rate of the first two weeks, but it's likely the speed of enrollment will ramp up, since as of Friday only 54 of the study's 89 sites were operating, according to the company's email to its researchers.
     
    Moderna's numbers did increase significantly from the first week of the trial to the second week.
    Even if Moderna does reach its goal of full enrollment during the month of September, the company still won't have a vaccine on the market by Election Day, infectious disease experts say.
    "I don't see how that would be possible," said Dr. Paul Offit, a vaccinologist at Children's Hospital of Philadelphia.
    After Moderna enrolls its subjects and gives them their first shot, they then have to wait 28 days before giving them a second shot....

     

    Country / Region Tags: 
    Australia
    Canada
    China
    Europe
    Global
    UK - London
    Middle East
    SouthEast Asia
    United Kingdom
    United States
    General Topic Tags: 
    COVID-19
    Contagion
    Disease
    Government
    Health
    Pandemics
    Policy
    Politics
    Research
    Science
    Problem, Solution, SitRep, or ?: 
    Situation Report
    Groups this Group Post belongs to: 
    - Private group -

    Comments

    Tue, 2020-08-11 19:35 — mike kraft

    Trump says U.S. has reached deal with Moderna for 100 million doses of coronavirus vaccine Moderna separately said the deal for its vaccine is worth $1.53 billion and will give the federal government the option to purchase up to 400 million additional doses. Noah Higgins-Dunn CNBC
    • President Donald Trump on Tuesday announced the U.S. government will purchase 100 million doses of Moderna’s experimental coronavirus vaccine. 
    • Moderna separately said the deal for its vaccine, mRNA-1273, is worth $1.53 billion and will give the federal government the option to purchase up to 400 million additional doses.
    • The U.S. government’s deal with Moderna follows similar agreements it’s made with pharmaceutical giants Pfizer, Johnson and Johnson and other drug makers for their potential Covid-19 vaccines. ,,,
    howdy folks
    Page loaded in 0.485 seconds.